Ticker Details
Pulmonx Corporation
IPO Date:	October 1, 2020
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$57.44M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.11%
Avg Daily Range (30 D):	$0.07 | 4.50%
Avg Daily Range (90 D):	$0.07 | 4.00%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	155
Avg Trade Size (Sh.) (90 D):	138

Institutional Trades
Total Institutional Trades:	993
Avg Institutional Trade:	$1.66M
Avg Institutional Trade (30 D):	$.92M
Avg Institutional Trade (90 D):	$.92M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.62M
Avg Closing Trade (30 D):	$1.01M
Avg Closing Trade (90 D):	$1.01M
Avg Closing Volume:	66.97K

News

Jun 24, 2024 @ 12:16 PM 5 Medical Info Systems Stock to Buy for a Stable P... Source: Nalak Das

May 22, 2024 @ 1:55 PM How Much Upside is Left in Pulmonx (LUNG)? Wall St... Source: Zacks Equity Research

May 10, 2024 @ 12:29 PM 5 Medical Info Systems Stocks to Buy for Stable Re... Source: Nalak Das

May 6, 2024 @ 9:03 PM Pulmonx Announces Inducement Grants under Nasdaq L... Source: Pulmonx Corporation

May 6, 2024 @ 1:55 PM Wall Street Analysts See a 56.11% Upside in Pulmon... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.33	$-.25	$-1.33
Diluted EPS	$-1.33	$-.25	$-1.33
Revenue	$90.5M	$22.6M	$90.5M
Gross Profit	$67.14M	$17.54M	$67.14M
Net Income / Loss	$-54M	$-10.43M	$-54M
Operating Income / Loss	$-53.66M	$-9.9M	$-53.66M
Cost of Revenue	$23.36M	$5.06M	$23.36M
Net Cash Flow	$-1.15M	$-6.8M	$-1.15M
PE Ratio